In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model

Spine Journal

Volumn 6, Issue 5, 2006, Pages 500-506

  Phillips, Frank M ^a   Turner, A Simon ^b   Seim III, H B ^b   MacLeay, Jennifer ^b   Toth, Carol A ^c   Pierce, Allen R ^c   Wheeler, Donna L ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c Stryker Orthopaedics   (United States)

Author keywords

BMP 7 (OP 1); Growth factor; Kyphoplasty; Osteoporosis; Vertebral fracture

Indexed keywords

ANION; CARBOXYMETHYLCELLULOSE; CATION; OSTEOGENIC PROTEIN 1; POLYGLYCOLIC ACID;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BIOSPHERE; BONE DENSITY; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; DIETARY INTAKE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG RELEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE HEALING; FRAGILITY FRACTURE; IN VIVO STUDY; MORPHOMETRICS; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZATION; RISK REDUCTION; SHEEP; STATISTICAL SIGNIFICANCE; TRABECULAR BONE; VERTEBRA BODY;

ACIDOSIS; ANIMAL FEED; ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; COMPRESSIVE STRENGTH; DIET; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; INJECTIONS, INTRALESIONAL; MICROSPHERES; OSTEOPOROSIS; OVARIECTOMY; POLYGLYCOLIC ACID; SHEEP; SPINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 33747668900     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2006.01.014     Document Type: Article

References (29)

1. National Institute of Health. Osteoporosis prevention, diagnosis, and therapy. Consensus Statement (2000), National Institute of Health, Bethesda, MD 17:1-36
2. Riggs B.L., and Melton III L.J. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17 Suppl. 5 (1995) 505S-511S
3. Kanis J.A., Johnell O., Oden A., et al. Long term risk of osteoporotic fractures in Malmo. Osteoporosis Int 11 (2000) 669-674
4. Melton III L.J., Chrischilles E.A., Cooper C., et al. How many women have osteoporosis?. J Bone Min Res 7 (1992) 1005-1010
5. Gold D.T. The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone 18 (1996) 185S-189S
6. Gold D.T., and Lyles K.W. Fractures: effects on quality of life (1999), Academic, San Diego, London
7. Silverman S.L. The clinical consequences of vertebral compression fracture. Bone 13 Suppl. 2 (1992) S27-S31
8. Marcus R., Wong M., Heath III H., et al. Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocrine Rev 23 (2002) 16-37
9. Rittmaster R.S., Bolognese M., Ettinger M.P., et al. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab 85 (2000) 2127-2128
10. Friedlaender G.E., Perry C.R., Cole J.D., et al. Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the treatment of tibial nonunion: a prospective, randomized clinical trial comparing rhOP-1 with fresh bone autograft. J Bone Joint Surg 83-A Suppl. 1, Pt 2 (2001) S1151-S1164
11. Vaccaro A.R., Patel T., Fischgrund J., et al. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 29 (2004) 1885-1892
12. MacLeay JM, Olson J, Les CM, et al. Effect of a diet low in cation-anion balance (DCAD) on bone mineral density in mature ovariectomized ewes. 49th Trans Orthopaedic Research Society, #380, New Orleans, LA, Feb. 1-5, 2003.
13. MacLeay J.M., Olson J.D., Enns R.M., et al. Dietary-induced metabolic acidosis decreases bone mineral density in mature ovariectomized ewes. Calcif Tiss Int 75 (2004) 431-437
14. Millets JF, MacLeay JM, Turner AS, et al. Skeletal fragility associated with a low cation-anion difference diet in mature ewes. 49th Trans Orthopaedic Research Society, #54, Feb. 2003.
15. Mosekilde L., Ortoft G., Mosekilde L., et al. Estimation of vertebral body strength by dual photon absorbtiometry in elderly individuals: comparison between measurements of total vertebral and vertebral bone mineral. Bone 14 (1993) 667-673
16. Parfitt A.M., Drezner M.K., Glorieux F.H., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Min Res 2 (1987) 595-609
17. Gunderson H.J.G. The nucleator. J Microscopy 131 (1988) 291-310
18. Thomsen J.S., Ebbesen E.N., and Moskilde L. A new method of comprehensive static histomorphometry applied on human lumbar vertebral cancellous bone. Bone 27 (2000) 129-138
19. Thomsen J.S., Ebbesen E.N., and Mosekilde L.I. Zone-dependent changes in human vertebral trabecular bone: clinical implications. Bone 30 (2002) 664-669
20. Knutsen R., Wergedal J.E., Sampath T.K., et al. Osteogenic Protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Biochem Biophys Res Commun 194 (1993) 1352-1358
21. Sampath T.K., and Reddi A.H. Bone Morphogenetic Protein (BMP) implants as bone graft substitutes-promises and challenges. In: Laurencin C.T. (Ed). Bone graft substitutes (2003), ASTM International 194-213
22. Malpe R., Baylink D.J., and Sampath T.K. Evidence that human bone cells in culture contain binding sites for Osteogenic Protein-1. Biochem Biophys Res Commun 201 (1994) 1140-1147
23. Yeh L.C.C., Unda R., and Lee J.C. Osteogenic Protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol 185 (2000) 87-97
24. Ripamonti U., van den Heever B., Heliotis M., et al. Local delivery of bone morphogenetic proteins in primates using reconstituted basement membrane gel: tissue engineering with Matrigel. S African J Sci 98 (2002) 1-5
25. Day J.S., Ding M., and Bednarz P. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 22 (2004) 465-471
26. Phillips F.M., Wetzel F.T., Lieberman I., et al. An in vivo comparison of the potential for extravertebral cement leak after vertebroplasty and kyphoplasty. Spine 27 (2002) 2173-2179
27. Lu L., Stamatas G.N., and Mikos A. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res 50 (2000) 440-451
28. Oldham J.B., Lu L., Zhu X., et al. Biologic activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng 122 (2000) 289-292
29. Ruhe P.Q., Hedberg E.L., Padron N.T., et al. rhBMP-2 release from injectable poly (dl-lactic-co-glycolic acid)/ calcium-phosphate cement composites. J Bone Joint Surg 85-A Suppl. 3 (2003) 75-81